Abstract
The association between disease staging and peripheral lymphocyte count (PLC) was studied in 178 patients with histologically verified lung cancer. Mean PLC varied inversely with the stage of disease (p less than .01). The mean values were 2821, 2217, and 1594 for Stages I, II and III respectively. Thoretical normal distributions were generated about the mean peripheral lymphocyte count for each stage. Relative frequencies of lung cancer staging based on the PLC are estimated utilizing these curves.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Krant M. J., Manskopf G., Brandrup C. S., Madoff M. A. Immunologic alterations in bronchogenic cancer. Sequential study. Cancer. 1968 Apr;21(4):623–631. doi: 10.1002/1097-0142(196804)21:4<623::aid-cncr2820210414>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- Papatestas A. E., Kark A. E. Peripheral lymphocyte counts in breast carcinoma. An index of immune competence. Cancer. 1974 Dec;34(6):2014–2017. doi: 10.1002/1097-0142(197412)34:6<2014::aid-cncr2820340620>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]